2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline

C192H132N22O — CID 158393414

IUPAC2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline
SMILESCC(C)(C)c1ccc(-c2nnc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)o2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)n2)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-c6nnc(-c7ccccc7)n6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-n6c(-c7ccccc7)cnc6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1
InChIInChI=1S/C49H32N6.C49H33N5.C48H32N6.C46H35N5O/c1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)50-43)51-49(55(45)40-21-11-4-12-22-40)39-31-27-34(28-32-39)33-25-29-38(30-26-33)48-53-46(36-17-7-2-8-18-36)52-47(54-48)37-19-9-3-10-20-37;1-5-15-36(16-6-1)44-33-50-48(38-19-9-3-10-20-38)53(44)41-31-29-35(30-32-41)34-25-27-39(28-26-34)49-52-46-42-23-13-14-24-43(42)51-45(37-17-7-2-8-18-37)47(46)54(49)40-21-11-4-12-22-40;1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)49-43)50-46(53(45)39-19-9-3-10-20-39)37-29-25-33(26-30-37)34-27-31-38(32-28-34)48-52-51-47(36-17-7-2-8-18-36)54(48)40-21-11-4-12-22-40;1-46(2,3)36-28-26-35(27-29-36)45-50-49-44(52-45)34-24-20-31(21-25-34)30-18-22-33(23-19-30)43-48-41-38-16-10-11-17-39(38)47-40(32-12-6-4-7-13-32)42(41)51(43)37-14-8-5-9-15-37/h1-32H;1-33H;1-32H;4-29H,1-3H3
InChIKeyGXGBQECFLXRWOI-UHFFFAOYSA-N
MW2763.32 g/mol
LogP46.93
Rot. Bonds27

About 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline

2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline (PubChem CID 158393414) has the molecular formula C192H132N22O and a molecular weight of 2763.32 g/mol. Its IUPAC name is 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline.

Molecular Properties

Compound Name2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline
PubChem CID158393414
Molecular FormulaC192H132N22O
Molecular Weight2763.32 g/mol
Exact Mass2761.10
IUPAC Name2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline
SMILESCC(C)(C)c1ccc(-c2nnc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)o2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)n2)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-c6nnc(-c7ccccc7)n6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-n6c(-c7ccccc7)cnc6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1
InChIInChI=1S/C49H32N6.C49H33N5.C48H32N6.C46H35N5O/c1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)50-43)51-49(55(45)40-21-11-4-12-22-40)39-31-27-34(28-32-39)33-25-29-38(30-26-33)48-53-46(36-17-7-2-8-18-36)52-47(54-48)37-19-9-3-10-20-37;1-5-15-36(16-6-1)44-33-50-48(38-19-9-3-10-20-38)53(44)41-31-29-35(30-32-41)34-25-27-39(28-26-34)49-52-46-42-23-13-14-24-43(42)51-45(37-17-7-2-8-18-37)47(46)54(49)40-21-11-4-12-22-40;1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)49-43)50-46(53(45)39-19-9-3-10-20-39)37-29-25-33(26-30-37)34-27-31-38(32-28-34)48-52-51-47(36-17-7-2-8-18-36)54(48)40-21-11-4-12-22-40;1-46(2,3)36-28-26-35(27-29-36)45-50-49-44(52-45)34-24-20-31(21-25-34)30-18-22-33(23-19-30)43-48-41-38-16-10-11-17-39(38)47-40(32-12-6-4-7-13-32)42(41)51(43)37-14-8-5-9-15-37/h1-32H;1-33H;1-32H;4-29H,1-3H3
InChIKeyGXGBQECFLXRWOI-UHFFFAOYSA-N
XLogP46.93
TPSA248.96 Ų
H-Bond Donors
H-Bond Acceptors23
Rotatable Bonds27
Heavy Atoms215
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002763.32
LogP ≤ 546.93
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1023

Analyze 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157163912
methane;7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;7-methyl-2-(2-propan-2-ylphenyl)-9-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]purin-8-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 157371199
16-(4-Imidazo[1,2-a]pyrimidin-2-ylphenyl)-9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;9-[3-methyl-5-(trifluoromethyl)phenyl]-16-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaene;2-phenyl-5-(9-phenyl-4,9-diazahexacyclo[13.6.2.02,10.03,8.012,22.019,23]tricosa-1(22),2(10),3(8),4,6,11,13,15,17,19(23),20-undecaen-16-yl)-1,3,4-oxadiazole
CID 158772688
2-[3,5-Bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole;2-[3,5-bis[3-phenyl-6-(trifluoromethyl)quinoxalin-2-yl]phenyl]-3-phenyl-6-(trifluoromethyl)quinoxaline;2-[3-(trifluoromethyl)phenyl]-5-[4-[tris[4-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]phenyl]-1,3,4-oxadiazole
CID 159951318
2-[3,5-Bis(5-naphthalen-1-yl-1,3,4-oxadiazol-2-yl)phenyl]-5-naphthalen-1-yl-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-(4-ethylphenyl)-5-(4-phenylphenyl)-1,2,4-triazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;3-(4-tert-butylphenyl)-4-phenyl-5-(4-phenylphenyl)-1,2,4-triazole;2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline;4,7-diphenyl-1,10-phenanthroline;2-[4-[1,1,1,3,3,3-hexafluoro-2-[4-[5-(4-phenylphenyl)-1,3,4-oxadiazol-2-yl]phenyl]propan-2-yl]phenyl]-5-(4-phenylphenyl)-1,3,4-oxadiazole;4-naphthalen-1-yl-3,5-diphenyl-1,2,4-triazole;9-[4-(3-phenylimidazo[4,5-b]pyridin-2-yl)phenyl]carbazole
CID 160130312
CID 160248464
CID 160248464
2,7-Bis(4-hexylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline;2-[3,5-bis(1-phenylbenzimidazol-2-yl)phenyl]-1-phenylbenzimidazole;2-[3,5-bis[3-phenyl-6-(trifluoromethyl)quinoxalin-2-yl]phenyl]-6-methyl-3-phenylquinoxaline;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(3-methylphenyl)-5-[4-[tris[4-[5-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-yl]phenyl]methyl]phenyl]-1,3,4-oxadiazole
CID 160311315
1-[4,6-Bis(2-methylbenzimidazol-1-yl)-1,3,5-triazin-2-yl]-2-methylbenzimidazole;9-butan-2-ylcarbazole;2-(4-tert-butylphenyl)-5-(4-phenylphenyl)-1,3,4-oxadiazole;2-(2,4-difluorobenzene-6-id-1-yl)pyridine;bis(iridium);2-phenylpyridine;2-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyridine
CID 161135612
7-[[4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]methyl]-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-6-one;4-[[6-oxo-2-(2-propan-2-ylphenyl)-5H-pyrrolo[2,3-d]pyrimidin-7-yl]methyl]benzonitrile;2-(2-propan-2-ylphenyl)-7-[(1R)-1-[4-(triazol-1-yl)phenyl]ethyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one;2-(2-propan-2-ylphenyl)-7-[[4-[3-(trifluoromethyl)pyrazol-1-yl]phenyl]methyl]-5H-pyrrolo[2,3-d]pyrimidin-6-one
CID 167617890
N-[[2-fluoro-4-[5-[4-[7-[3-fluoro-4-[[(5-methyl-[1,2,4]triazolo[4,3-a]pyridin-3-yl)amino]methyl]phenyl]-5-[[4-[7-[3-fluoro-4-[([1,2,4]triazolo[4,3-a]pyridin-3-ylamino)methyl]phenyl]-5-[[4-[7-[3-fluoro-4-[[[6-(trifluoromethyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]amino]methyl]phenyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]methyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]methyl]-3H-imidazo[4,5-b]pyridin-2-yl]pyrazol-1-yl]-2-(1-methylpyrazol-4-yl)-3H-imidazo[4,5-b]pyridin-7-yl]phenyl]methyl]-5-phenyl-1,3,4-oxadiazol-2-amine
CID 174365372
5-(4-Tert-butylphenyl)-3-[2-[3-[1-[3-(4,7-diphenyl-1,10-phenanthrolin-1-ium-1-yl)phenyl]benzimidazol-2-yl]-5-(1-phenylbenzimidazol-2-yl)phenyl]-3-phenylbenzimidazol-5-yl]-2-(4-phenylphenyl)-1,3,4-oxadiazol-3-ium
CID 91238558
6-[5-(5-Fluoro-2-methyl-4-pyridinyl)-1,3,4-oxadiazol-2-yl]-1,3,3-trimethylindol-2-one;1,3,3-trimethyl-6-[2-(6-methyl-3-pyridinyl)pyrimidin-5-yl]indol-2-one
CID 118526031

Frequently Asked Questions

What is the IUPAC name of 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline?
The IUPAC name of 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline (CID 158393414) is 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline.
What is the SMILES notation for 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline?
The canonical SMILES for 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline is CC(C)(C)c1ccc(-c2nnc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)o2)cc1.c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4ccc(-c5nc6c7ccccc7nc(-c7ccccc7)c6n5-c5ccccc5)cc4)cc3)n2)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-c6nnc(-c7ccccc7)n6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1.c1ccc(-c2nc3ccccc3c3nc(-c4ccc(-c5ccc(-n6c(-c7ccccc7)cnc6-c6ccccc6)cc5)cc4)n(-c4ccccc4)c23)cc1.
What is the InChIKey of 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline?
The InChIKey is GXGBQECFLXRWOI-UHFFFAOYSA-N. The full InChI is InChI=1S/C49H32N6.C49H33N5.C48H32N6.C46H35N5O/c1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)50-43)51-49(55(45)40-21-11-4-12-22-40)39-31-27-34(28-32-39)33-25-29-38(30-26-33)48-53-46(36-17-7-2-8-18-36)52-47(54-48)37-19-9-3-10-20-37;1-5-15-36(16-6-1)44-33-50-48(38-19-9-3-10-20-38)53(44)41-31-29-35(30-32-41)34-25-27-39(28-26-34)49-52-46-42-23-13-14-24-43(42)51-45(37-17-7-2-8-18-37)47(46)54(49)40-21-11-4-12-22-40;1-5-15-35(16-6-1)43-45-44(41-23-13-14-24-42(41)49-43)50-46(53(45)39-19-9-3-10-20-39)37-29-25-33(26-30-37)34-27-31-38(32-28-34)48-52-51-47(36-17-7-2-8-18-36)54(48)40-21-11-4-12-22-40;1-46(2,3)36-28-26-35(27-29-36)45-50-49-44(52-45)34-24-20-31(21-25-34)30-18-22-33(23-19-30)43-48-41-38-16-10-11-17-39(38)47-40(32-12-6-4-7-13-32)42(41)51(43)37-14-8-5-9-15-37/h1-32H;1-33H;1-32H;4-29H,1-3H3.
What are the key properties of 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline?
2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline has a molecular weight of 2763.32 g/mol, XLogP of 46.93, 27 rotatable bonds, 0 hydrogen bond donors, and 23 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(4-tert-butylphenyl)-5-[4-[4-(3,4-diphenylimidazo[4,5-c]quinolin-2-yl)phenyl]phenyl]-1,3,4-oxadiazole;2-[4-[4-(2,5-diphenylimidazol-1-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline;2-[4-[4-(4,5-diphenyl-1,2,4-triazol-3-yl)phenyl]phenyl]-3,4-diphenylimidazo[4,5-c]quinoline is sourced from PubChem (CID 158393414), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).